Cutaquig 165 mg/ml

Cutaquig 165 mg/ml is a medicine authorised by Swissmedic under authorisation number 68222. The authorisation holder is Octapharma AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 February 2022 and the authorisation is valid without a time limit. ATC code J06BA01 places the medicine in the group Immune sera and immunoglobulins.

  • Dispensing category B
  • Authorisation number 68222
  • ATC J06BA01
  • Blood products
Authorisation data
Authorisation number68222
NameCutaquig 165 mg/ml
Full nameCutaquig 165 mg/ml, Injektionslösung
Authorisation holderOctapharma AG
Medicinal product codeBlood products
Dispensing categoryB · Prescription only
ATC codeJ06BA01
First authorisation15 February 2022
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Cutaquig 165 mg/ml, InjektionslösungB15 February 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)J06BA0108.09.B
210Durchstechflasche(n)J06BA0108.09.B
320Durchstechflasche(n)J06BA0108.09.B
41Durchstechflasche(n)J06BA0108.09.B
510Durchstechflasche(n)J06BA0108.09.B
620Durchstechflasche(n)J06BA0108.09.B
71Durchstechflasche(n)J06BA0108.09.B
810Durchstechflasche(n)J06BA0108.09.B
920Durchstechflasche(n)J06BA0108.09.B
101Durchstechflasche(n)J06BA0108.09.B
1110Durchstechflasche(n)J06BA0108.09.B
1220Durchstechflasche(n)J06BA0108.09.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Cutaquig 165 mg/ml authorised in Switzerland?

Yes. Cutaquig 165 mg/ml is authorised by Swissmedic under authorisation number 68222, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Cutaquig 165 mg/ml have?

Cutaquig 165 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Cutaquig 165 mg/ml?

The authorisation holder is Octapharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com